微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.76% | 61.47% | -58.49% | 63/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.24% | 153.88% | -1.62% | 65/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.31% | 167.24% | 128.04% | 69/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.89% | 129.72% | 73.39% | 85/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.09% | 146.58% | 113.85% | 93/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -7.87% | 14.64% | -22.78% | 126/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -6.41% | -499.07% | -0.79% | 129/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -6.36% | -7166.67% | -171.79% | 130/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.34% | -490% | 74.62% | 132/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -9.22% | -185.77% | -761.68% | 124/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -1.07% | -108.55% | -1288.89% | 116/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.09% | -98.91% | -85% | 116/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.6% | -89.51% | -94.42% | 104/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.75% | -55.63% | -14.14% | 39/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12.52% | -30.75% | 51.03% | 18/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.29% | -4.05% | 44.93% | 24/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.72% | 37.83% | -76.39% | 6/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 24.23% | -30.77% | 34.02% | 12/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 18.08% | -35.77% | 109.26% | 8/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.64% | -52.61% | 108.19% | 29/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.15% | -57.22% | -88.14% | 21/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 35% | -13.98% | 24.33% | 1/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 28.15% | 1366.15% | 54.42% | 1/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 18.23% | 1157.24% | 87.94% | 2/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 9.7% | -19.7% | -76.16% | 1/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 40.69% | 1894.61% | 2019.27% | 1/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.92% | 40.15% | 32.41% | 92/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.45% | 222.22% | -88% | 92/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 12.08% | 1648.72% | 492.16% | 1/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.04% | 482.86% | 48.91% | 110/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.37% | 813.33% | 204.44% | 90/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.45% | 152.94% | 157.69% | 99/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -0.78% | 25.71% | -322.86% | 84/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.35% | -91.84% | 133.33% | 105/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.15% | -96.72% | 117.65% | 79/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.85% | -115.48% | 19.05% | 86/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -1.05% | -127.56% | -124.48% | 78/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 4.29% | -63.08% | -6.33% | 77/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 4.58% | 2% | -16.58% | 50/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 5.49% | 2% | 44.09% | 33/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 3.81% | 2% | -67.21% | 19/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |